Clinical trial
Gemcitabine for Advanced Salivary Cancer: A Phase II Study
NCT00003744 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gemcitabine for Advanced Salivary Cancer: A Phase II Study
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 1998
- Completion date
- May 31, 2004
- Enrollment
- 16 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer